Funded Startups in Branford
Among the 7 most recent funded companies in Branford, Connecticut, the largest disclosed rounds belong to IsoPlexis ($125M Post-IPO Equity, October 2021) a…
Among the 7 most recent funded companies in Branford, Connecticut, the largest disclosed rounds belong to IsoPlexis ($125M Post-IPO Equity, October 2021) and Princeton Medspa Partners ($120M, June 2024). Saphlux raised $16M in a Series B in December 2022, and Azitra closed a $2M round on January 14, 2025 — one day after BEKHealth's undisclosed round. The records span just over three years, from October 2021 through January 2025.
Four of the seven rounds are classified as Series Unknown, and three companies — BEKHealth, Sachem Capital, and DotLab — have not disclosed their amounts. Biotechnology accounts for two of the seven companies (Azitra and IsoPlexis), making it the most represented sector. The other five span health care, financial services, AI, consumer electronics, and data and analytics, with no single vertical dominating.
Most recent rounds
7 shownRelated listings
Frequently asked
What are the largest disclosed funding rounds among Branford companies in this data?
IsoPlexis leads with $125M raised in a Post-IPO Equity round in October 2021, followed by Princeton Medspa Partners at $120M in June 2024. Saphlux's Series B in December 2022 at $16M and Azitra's January 2025 round at $2M are the other two disclosed amounts; the remaining three rounds have no public figures.
Which sectors are most represented among recently funded Branford companies?
Biotechnology appears twice — Azitra (January 2025) and IsoPlexis (October 2021) — making it the most common sector in this dataset. The other five companies each represent a distinct vertical: health care, financial services, AI, consumer electronics, and data and analytics.
What funding stages are Branford companies typically at?
Four of the seven rounds are classified as Series Unknown, which limits stage visibility. The three clearly staged rounds are a Seed (DotLab, September 2023), a Series B (Saphlux, December 2022), and a Post-IPO Equity round (IsoPlexis, October 2021).
Which Branford companies have not disclosed their round amounts?
BEKHealth, Sachem Capital, and DotLab all list undisclosed amounts. All three are also classified as Series Unknown rounds, meaning neither stage nor size is confirmed in this dataset.
Which companies closed the most recent funding rounds in Branford?
Azitra and BEKHealth both closed rounds in January 2025 — Azitra on January 14 and BEKHealth on January 13. Both operate in life sciences-adjacent sectors: biotechnology and health care, respectively.
Is there any post-IPO activity among these Branford companies?
IsoPlexis, a biotechnology company, is the only post-IPO entity in this dataset. It raised $125M in a Post-IPO Equity round in October 2021, the earliest round represented in this listing.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.